Issue link: http://www.e-digitaleditions.com/i/883179
Tablets & Capsules October 2017 9 The deals are valued at $1.38 billion. An earlier agreement calls for Teva to sell its Paragard contraceptive busi- ness to Cooper Companies for $1.1 billion. FDA approves first US treatment for Chagas SILVER SPRINGS, MD—The FDA granted accelerated approval of benznidazole to treat patients age 2 to 12 with Chagas disease. It is the first Chagas treatment approved in the USA. The product is manufac- tured by Chemo Research, Madrid, Spain. Chagas disease, or American trypanosomiasis, is a parasitic infec- tion transmitted through contact with the feces of a certain insect, blood transfusions, and from a mother to her child during preg- nancy. It primarily affects people liv- ing in rural parts of Latin America. Dupont expands probiotic pilot site MADISON, WI—DuPont Nutri- tion & Health invested $10 million to expand its probiotic development and scale-up work site here. The expansion improves the site's equip- ment, data collection, labs, and instrumentation. It also allows the company to conduct more simultane- ous development projects. Aker BioMarine acquires Neptune's krill-oil inventory LYSAKER, Norway—Aker Bio- Marine acquired the krill-oil inven- tory of Neptune Technologies & Bioressources for $34 million. Aker will serve as the exclusive supplier of krill oil to Neptune's Solutions Business, which produces krill-oil softgels. Neptune, Laval, PQ, Canada, plans to use the money to invest in cannabis-oil extraction and other areas. Lallemand has first probiotic sites to receive USP certificate MONTREAL, PQ, Canada— Lallemand Health Solutions' probi- otic production plants here and in Mirabel, PQ, Canada, passed the United States Pharmacopeia (USP) quality systems GMP audit. They're the first probiotic production facili- ties to receive the quality certificate. The company specializes in the development, production, and mar- keting of yeasts and bacteria. Briefly noted… The FDA approved Tracleer (bosentan) to treat patients age 3 and older with idiopathic or congen- ital pulmonary arterial hypertension. It is manufactured by Actelion Pharmaceuticals US, South San Francisco, CA. Lupin won FDA approval of its generic equivalent of G.S. Searle's Flagyl (metronidazole) tablets, an antibiotic. SANITARY/USDA-ACCEPTED • PNEUMATIC CONVEYING COMPONENTS & SYSTEMS • BATCH & CONTINUOUS OPERATION MULTI-INGREDIENT HANDLING SYSTEMS • BATCH WEIGHING & SCALING SYSTEMS • UL-CONTROLS & CONTROL PACKAGES FDA-APPROVED/CERTIFIED MATERIALS OF CONSTRUCTION • 21 CFR PART 11 COMPLIANCE MOBILE VACUUM CONVEYING SYSTEMS • CIP DESIGNS Let us solve your pneumatic conveying challenges. Visit vac-u-max.com/pneumatic or call 800-VAC-U-MAX. More than 60 years of custom application experience in the pharmaceutical industry. Over 10,000 different powder and bulk materials handled—including Free-Flowing and Non-Free Flowing Powders. Technical expertise including FAT and SAT validation. And an airtight perfor- mance guarantee. It's what makes VAC-U-MAX as unique and trusted as the pharmaceutical process automation solutions we design. From sanitary components to fully automated batch or continuous systems, we create pharmaceutical processing solutions entirely around your needs and goals.